Skip to main content
    C

    CorMedix Inc (CRMD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.46
    +0.07 (+0.95%)

    Market Cap: $576.01M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    +9.23%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.11
    Range$-0.17 - $-0.05
    6 analysts
    EPS Revisions
    1
    0
    7d
    1
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.09-13.5%
    60d ago$-0.09-13.5%
    30d ago$-0.10-2.6%
    7d ago$-0.110.0%
    Current$-0.11
    Revenue Consensus
    $53M
    Range$51M - $58M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.03
    Range$-0.10 - $0.13
    6 analysts
    Revenue Consensus
    $83M
    Range$81M - $90M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.03---
    Sep 26EST
    		-$-0.11---
    Jun 26
    Reported Aug 13
    		$0.29$0.26+11.54%Beat+3.6%
    Mar 26
    Reported May 14
    		$0.35$0.33+6.06%Beat+16.7%
    Dec 25
    Reported Mar 5
    		$0.16N/A-78.24%Miss-27.2%
    Sep 25
    Reported Nov 12
    		$1.41$0.63+123.81%Beat+2920.0%
    Jun 25
    Reported Aug 7
    		$0.28$0.20+40.00%Beat+212.0%
    Mar 25
    Reported May 6
    		$0.30$0.25+20.00%Beat+220.0%
    Dec 24
    Reported Mar 25
    		$0.22$0.14+57.14%Beat+184.6%
    Sep 24
    Reported Oct 30
    		$-0.05$-0.10+50.00%Beat+70.6%
    Jun 24
    Reported Aug 14
    		$-0.25$-0.25+0.00%Beat+0.0%
    Mar 24
    Reported May 9
    		$-0.25$-0.28+10.71%Beat-4.2%
    Dec 23
    Reported Mar 12
    		$-0.26$-0.20-30.00%Miss-30.0%
    Sep 23
    Reported Nov 14
    		$-0.17$-0.21+19.05%Beat+0.0%
    Jun 23
    Reported Aug 8
    		$-0.25$-0.24-4.17%Miss-31.6%
    Mar 23
    Reported May 15
    		$-0.24$-0.20-20.00%Miss-33.3%
    Dec 22
    Reported Mar 30
    		$-0.20$-0.19-5.26%Miss+0.0%
    Sep 22
    Reported Nov 10
    		$-0.17$-0.23+26.09%Beat+22.7%
    Jun 22
    Reported Aug 11
    		$-0.19$-0.21+9.52%Beat-58.3%
    Mar 22
    Reported May 12
    		$-0.18$-0.22+18.18%Beat+10.0%
    Dec 21
    Reported Mar 29
    		$-0.20$-0.23+13.04%Beat-5.3%
    Sep 21
    Reported Nov 9
    		$-0.22$-0.18-22.22%Miss+0.0%
    Jun 21
    Reported Aug 12
    		$-0.12$-0.19+36.84%Beat+14.3%
    Mar 21
    Reported May 13
    		$-0.20$-0.18-11.11%Miss+4.8%
    Dec 20
    Reported Mar 30
    		$-0.19$-0.22+13.64%Beat+9.5%
    Sep 20
    Reported Nov 5
    		$-0.22$-0.25+12.00%Beat+0.0%
    Jun 20
    Reported Aug 10
    		$-0.14$-0.24+41.67%Beat+41.7%
    Mar 20
    Reported May 11
    		$-0.21$-0.23+8.70%Beat+4.5%
    Dec 19
    Reported Mar 16
    		$-0.21$-0.24+12.50%Beat-310.0%
    Sep 19
    Reported Nov 14
    		$-0.22$-0.25+12.00%Beat+60.0%
    Jun 19
    Reported Aug 13
    		$-0.24$-0.21-14.29%Miss+52.0%
    Mar 19
    Reported May 13
    		$-0.22$-0.28+21.43%Beat+68.6%
    Dec 18
    Reported Mar 14
    		$0.10N/A+125.00%Beat+113.0%
    Sep 18
    Reported Nov 14
    		$-0.55$-0.30-83.33%Miss+16.7%
    Jun 18
    Reported Aug 14
    		$-0.50$-0.50+0.00%Beat+25.4%
    Mar 18
    Reported May 15
    		$-0.70$-0.50-40.00%Miss+26.3%
    Dec 17
    Reported Mar 19
    		$-0.77$-0.60-28.33%Miss+3.8%
    Sep 17
    Reported Nov 9
    		$-0.66$-0.65-1.54%Miss-
    Jun 17
    Reported Aug 9
    		$-0.67$-0.80+16.25%Beat-
    Mar 17
    Reported May 10
    		$-0.95$-0.72-31.94%Miss-
    Dec 16
    Reported Mar 16
    		$-0.80$-1.07+25.23%Beat-

    Key Metrics

    Valuation
    P/E Ratio3.38EV/EBITDA2.04x
    Price/FCF2.34xFCF Yield42.79%
    Profitability
    Profit Margin40.50%Operating Margin42.10%
    ROE54.90%ROIC30.34%
    Financial Health
    Debt/Equity0.31xInterest Coverage53.54x
    Current Ratio2.56xQuick Ratio2.36x
    Trading Statistics
    Beta1.41Avg Volume995.09K
    52-Week High$13.0252-Week Low$6.12

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.34
    SMA 20$7.55
    SMA 50$7.83
    SMA 200$7.79
    EMA 10$7.43
    EMA 20$7.54
    EMA 50$7.75
    EMA 200$8.23

    MACD

    Line: -0.15Signal: -0.16Hist: 0.01

    ADX

    ADX: 13.7+DI: 21.7-DI: 17.6

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down68.0
    PSAR$7.09

    Bollinger Bands

    Upper Band$8.03
    Lower Band$7.07
    %B Position1273%(Upper)
    Band Width0.41

    RSI (14-Day)

    Neutral
    43.8

    Momentum Oscillators

    Stoch %K39.6
    Stoch %D36.7
    Williams %R-55.2
    ROC (10d)0.5%
    Momentum0.04
    CCI (20d)-6.6
    MFI (14d)58.2

    Volatility Measures

    ATR (14d)$0.26(3.5%)
    StdDev (20d)0.24
    Hist Vol23.2%(Moderate)

    Volume Flow

    VWAP$7.53
    OBV-15.8M
    AD Line-61.5M
    CMF (20d)0.015

    Volume Metrics

    Avg Vol (20d)1.0M
    Vol Ratio1.4x
    VWMA (20d)$7.51

    Pivot Points

    R3$7.78
    R2$7.66
    R1$7.52
    Pivot Point$7.40
    S1$7.26
    S2$7.14
    S3$7.00

    Advanced Oscillators

    TSI-19.93
    Ultimate Osc49.6
    KST-77.84

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$101.93M$127.43M$118.37M$100.65M$39.74M$39.08M$31.21M$11.46M$806,119$0$304,110$0
    Cost of Revenue$24.80M$22.30M$11.06M$7.57M$1.86M$1.60M$1.07M$634,650$509,839$818,539$53,507$0
    Gross Profit$77.13M$105.12M$107.31M$93.08M$37.87M$37.48M$30.03M$10.77M$296,280$-818,539$-53,507$0
    Operating Expenses$34.22M$41.46M$48.18M$41.73M$18.33M$17.36M$17.25M$14.06M$15.60M$15.89M$15.67M$10.47M
    R&D$6.68M$7.21M$8.60M$5.10M$2.44M$3.19M$1.73M$727,119$650,988$837,445$2.29M$2.66M
    SG&A$15.09M$21.72M$23.57M$25.45M$9.50M$9.69M$7.11M$6.58M$7.56M$8.71M$2.58M$3.74M
    Operating Income$42.91M$63.66M$59.13M$51.35M$19.54M$20.13M$12.94M$-3,287,336$-15,300,826$-16,704,236$-15,668,744$-10,467,283
    Interest Income$2.55M$0$889,982$1.56M$0$0$510,592$553,856$657,366$857,186$920,043$765,241
    Interest Expense$4.18M$8.01M$1.82M$948,242$0$0$9,602$10,007$6,556$9,835$6,556$13,113
    Income Before Tax$38.73M$55.65M$56.45M$52.58M$20.35M$20.64M$13.46M$-2,776,812$-14,151,489$-15,860,893$-14,754,029$-9,744,354
    Income Tax Expense$12.74M$17.04M$42.43M$-55,986,802$522,000$0$-230$0$0$-1,394,770$0$0
    Net Income$25.99M$38.60M$14.02M$108.56M$19.83M$20.64M$13.46M$-2,776,812$-14,151,489$-14,466,123$-14,754,029$-9,744,354
    EBITDA$46.73M$66.19M$67.26M$52.02M$20.51M$20.81M$13.14M$-3,205,947$-14,688,961$-16,650,774$-15,614,009$-10,444,620
    EBIT$36.19M$55.65M$55.99M$51.96M$20.35M$20.64M$12.96M$-3,320,661$-14,802,299$-16,708,244$-15,667,516$-10,496,482
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CRMD

    News

    Actinium Names Former CorMedix CFO Matt David as Finance Chief

    Actinium Pharmaceuticals has appointed Matt David, former CFO of CorMedix, as its new chief financial officer and principal financial officer. David brings over two decades of experience in biopharmaceutical leadership...

    TOKENPOST•10/15/26•Neutral

    CorMedix Q3 2026 Earnings Date and Estimates

    CorMedix (NASDAQ:CRMD) is projected to announce its Q3 2026 earnings before market open on Wednesday, November 11, 2026...

    MarketBeat•10/14/26•Somewhat-Bearish

    RBC Capital Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $14

    RBC Capital has reiterated its Buy rating for CorMedix (CRMD.US) and maintained a target price of $14. This indicates a continued positive outlook from the firm regarding CorMedix's stock performance.

    Moomoo•10/9/26•Bullish

    US218939AB27 Bond Yield and Price — BONDSCOM:US218939AB27

    This page provides details for the CorMedix Inc. 4.0% 01-AUG-2030 bond, identified by ISIN US218939AB27. Key terms include a face value of $1,000, semi-annual coupon payments, and a maturity date of August 1, 2030...

    TradingView•10/7/26•Neutral

    (CRMD) Movement Within Algorithmic Entry Frameworks

    This article analyzes Cormedix Inc. (NASDAQ: CRMD) using algorithmic entry frameworks, highlighting weak sentiment across all time horizons that supports a short bias. It details three institutional trading...

    Stock Traders Daily•10/7/26•Bearish

    CRMD Valuation and Fair Value

    P/E
    3.4x
    Forward P/E
    46.5x
    EV/EBITDA
    2.0x
    P/FCF
    2.3x
    PEG
    0.0x
    P/B
    1.3x
    See GNG's fair value

    CRMD Profitability: Margins, ROIC and FCF

    Gross margin
    85.3%
    Operating margin
    42.1%
    Net margin
    40.5%
    ROIC
    30.3%
    ROE
    54.9%
    FCF margin
    55.9%
    FCF yield
    42.8%

    CRMD Competitors

    CompanyTicker
    Fulgent Genetics IncFLGT
    Orthopediatrics CorpKIDS
    Solid Biosciences LLCSLDB
    Prime Medicine, Inc. Common StockPRME
    Climb Bio IncCLYM
    DBV TechnologiesDBVT
    Nuvectis Pharma IncNVCT
    Sagimet Biosciences Inc. Series A Common StockSGMT

    Sector: Healthcare

    CRMD Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    3
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    CRMD Bull Case vs Bear Case

    Bull case

    • CRMD earns a 30.3% return on invested capital.
    • CRMD converts 55.9% of revenue into free cash flow.
    • CRMD has a 40.5% net profit margin.

    CRMD Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    28.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.11
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 2 down

    Frequently Asked Questions About CRMD

    Does CRMD pay dividends?

    CorMedix Inc (CRMD) does not currently pay a regular dividend.

    What is CRMD's P/E ratio?

    CorMedix Inc has a price-to-earnings (P/E) ratio of 3.38.

    What is CRMD's market cap?

    CorMedix Inc (CRMD) has a market capitalization of $576.01M with a current stock price of $7.46.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In